The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

A RIKEN study shows that squeezing the right amount of potassium ions between the atomic layers of molybdenum disulfide can ...

Discover Acumen Pharmaceuticals' progress on Alzheimer's treatment sabirnetug, Phase 2 trial updates, biomarker advancements, and financial strategies.

Cinnamon and its byproducts have been used for many years because of their antidiabetic effect. In a joint study conducted by ...

BASF SE (Ludwigshafen, Germany) and Forestal de Atlántico S.A. (Forestal) have signed an early disclosure agreement (EDA) ...

Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...